Fatema Khaton

Dhaka, C 1212, Bangladesh

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Longevity and Magnitude of Antibody Responses After Homologous and Heterologous COVID-19 Booster Vaccinations in Bangladesh.

Longevity and Magnitude of Antibody Responses After Homologous and Heterologous COVID-19 Booster Vaccinations in Bangladesh.

Journal: Vaccines

Published: May 19, 2026

Spike specific IgG3 and nucleocapsid IgG response in serum serve as distinguishing immunological markers between SARS-CoV-2 infection and vaccination.

Spike specific IgG3 and nucleocapsid IgG response in serum serve as distinguishing immunological markers between SARS-CoV-2 infection and vaccination.

Journal: Frontiers in immunology

Published: October 29, 2024

Appearance of tolerance-induction and non-inflammatory SARS-CoV-2 spike-specific IgG4 antibodies after COVID-19 booster vaccinations.

Appearance of tolerance-induction and non-inflammatory SARS-CoV-2 spike-specific IgG4 antibodies after COVID-19 booster vaccinations.

Journal: Frontiers in immunology

Published: October 09, 2023

The Fatal Clinical Outcome of Severe COVID-19 in Hospitalized Patients: Findings from a Prospective Cohort Study in Dhaka, Bangladesh.

The Fatal Clinical Outcome of Severe COVID-19 in Hospitalized Patients: Findings from a Prospective Cohort Study in Dhaka, Bangladesh.

Journal: Medicina (Kaunas, Lithuania)

Published: May 08, 2023

Longevity of memory B cells and antibodies, as well as the polarization of effector memory helper T cells, are associated with disease severity in patients with COVID-19 in Bangladesh.

Longevity of memory B cells and antibodies, as well as the polarization of effector memory helper T cells, are associated with disease severity in patients with COVID-19 in Bangladesh.

Journal: Frontiers in immunology

Published: September 23, 2022

Co-administration of Oral Cholera Vaccine With Oral Polio Vaccine Among Bangladeshi Young Children: A Randomized Controlled Open Label Trial to Assess Interference.

Co-administration of Oral Cholera Vaccine With Oral Polio Vaccine Among Bangladeshi Young Children: A Randomized Controlled Open Label Trial to Assess Interference.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: June 13, 2022

Covishield vaccine induces robust immune responses in Bangladeshi adults.

Covishield vaccine induces robust immune responses in Bangladeshi adults.

Journal: IJID regions

Published: March 04, 2022

Seroprevalence of SARS-CoV-2 antibodies in Bangladesh related to novel coronavirus infection.

Seroprevalence of SARS-CoV-2 antibodies in Bangladesh related to novel coronavirus infection.

Journal: IJID regions

Published: July 28, 2021

Disease characteristics and serological responses in patients with differing severity of COVID-19 infection: A longitudinal cohort study in Dhaka, Bangladesh.

Disease characteristics and serological responses in patients with differing severity of COVID-19 infection: A longitudinal cohort study in Dhaka, Bangladesh.

Journal: PLoS neglected tropical diseases

Published: June 22, 2021

A phase I/II study to evaluate safety, tolerability and immunogenicity of Hillchol®, an inactivated single Hikojima strain based oral cholera vaccine, in a sequentially age descending population in Bangladesh.

A phase I/II study to evaluate safety, tolerability and immunogenicity of Hillchol®, an inactivated single Hikojima strain based oral cholera vaccine, in a sequentially age descending population in Bangladesh.

Journal: Vaccine

Published: February 08, 2021

Vibrio cholerae O1 transmission in Bangladesh: insights from a nationally representative serosurvey.

Vibrio cholerae O1 transmission in Bangladesh: insights from a nationally representative serosurvey.

Journal: The Lancet. Microbe

Published: December 21, 2020

Showing 1-11 of 11

Last Updated: 09/26/2026